VIVS
VivoSim Labs, Inc.
There isn't enough reported data to score VIVS yet.
VIVS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
VIVS's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
VIVS PE Valuation
VIVS has no meaningful PE right now: it lost money over the past year.
VIVS Forward outlook
There aren't enough analyst estimates for VIVS to show an outlook.
VIVS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.51 | -666% |
| Q2 2026 | -$4.46 | -$4.38 |
| Q1 2026 | -$5.35 | -$3.65 |
| Q4 2025 | $1.87 | +$11.95 |
| Q3 2025 | $0.62 | +$13.22 |
| Q2 2025 | -$0.08 | +$16.36 |
| Q1 2025 | -$1.70 | +$17.50 |
| Q4 2024 | -$10.08 | +$16.08 |
VIVS has swung to a loss: it lost $3.51 per share over the past year, after a profit the year before.
VIVS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $51K | +82% |
| Q2 2026 | $18K | -51% |
| Q1 2026 | $40K | -22% |
| Q4 2025 | $26K | +8.3% |
| Q3 2025 | $28K | -6.7% |
| Q2 2025 | $37K | -5.1% |
| Q1 2025 | $51K | +76% |
| Q4 2024 | $24K | +380% |
VIVS's revenue is recovering but still below its 2019 peak: $51,000 last quarter, up 82% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6502% | +2909 points |
| Q2 2026 | -15328% | -7449 points |
| Q1 2026 | -7968% | -1783 points |
| Q4 2025 | -10577% | +3873 points |
| Q3 2025 | -9411% | -717 points |
| Q2 2025 | -7878% | +804 points |
| Q1 2025 | -6184% | +4492 points |
| Q4 2024 | -14450% | +59150 points |
VIVS's operating margin was −6502% last quarter, up 2909 points from the same quarter a year ago.
VIVS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.2M | +$704K |
| Q1 2026 | -$2.2M | -$203K |
| Q4 2025 | -$2.3M | -$470K |
| Q2 2025 | -$3.9M | -$957K |
| Q1 2025 | -$2M | +$636K |
| Q4 2024 | -$1.8M | +$1.7M |
| Q3 2024 | -$2.7M | +$521K |
| Q2 2024 | -$3M | +$2.3M |
VIVS has burned cash in almost every quarter: −$10M over the past year, against −$10M the year before.
VIVS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +214% | +11.2M shares |
| 1 year | +557% | +13.9M shares |
| 3 years | +2165% | +15.7M shares |
| 5 years | +2777% | +15.9M shares |
| Available history | +2925% | +15.9M shares |
VIVS has 16M diluted shares, up 557% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
| Q4 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
VIVS Net Leverage
VIVS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VIVS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.5 | Oversold |
| Stochastic | 3.0 | Oversold |
VIVS's weekly RSI is 23 (oversold) and its Stochastic is 3 (oversold).
VIVS PE vs Healthcare Sector
| Metric | VIVS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
VIVS has no meaningful PE right now: it lost money over the past year.
VIVS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.17 | 18% below |
| 20 week MA | $0.33 | 58% below |
| 50 week MA | $1.18 | 88% below |
| 100 week MA | $1.95 | 93% below |
| 200 week MA | $8.06 | 98% below |
VIVS is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
VIVS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $96.0 | $191.5 | +100% |
| 2021 | $191.5 | $48.2 | -75% |
| 2022 | $48.2 | $19.1 | -60% |
| 2023 | $19.1 | $13.3 | -30% |
| 2024 | $13.3 | $3.67 | -72% |
| 2025 | $3.67 | $2.01 | -45% |
| 2026 YTD | $2.01 | $0.14 | -93% |
VIVS has finished five years in a row lower, and it's down 93% so far in 2026.